Flow-Cytometric Monitoring of Minimal Residual Disease in Pediatric Patients With Acute Myeloid Leukemia: Recent Advances and Future Strategies

Minimal residual disease (MRD) by multiparametric flow cytometry (MFC) has been recently shown as a strong and independent prognostic marker of relapse in pediatric AML (pedAML) when measured at specific time points during Induction and/or Consolidation therapy. Hence, MFC-MRD has the potential to r...

Descripción completa

Detalles Bibliográficos
Autores principales: Buldini, Barbara, Maurer-Granofszky, Margarita, Varotto, Elena, Dworzak, Michael N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798174/
https://www.ncbi.nlm.nih.gov/pubmed/31681710
http://dx.doi.org/10.3389/fped.2019.00412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798174/
https://www.ncbi.nlm.nih.gov/pubmed/31681710
http://dx.doi.org/10.3389/fped.2019.00412

Ejemplares similares